Sequential CD19/22 CAR T-cell immunotherapy following autologous stem cell transplantation for central nervous system lymphoma

Chimeric antigen receptor (CAR) T-cell immunotherapy following autologous stem cell transplantation (ASCT) is a promising method for refractory or relapsed multiple myeloma, but explicit data for central nervous system lymphoma (CNSL) are lacking. Here, we treated 13 CNSL patients with ASCT sequenti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Cancer J
Main Authors: Wu, Jiaying, Meng, Fankai, Cao, Yang, Zhang, Yicheng, Zhu, Xiaojian, Wang, Na, Wang, Jue, Huang, Lifang, Zhou, Jianfeng, Xiao, Yi
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8282870/
https://ncbi.nlm.nih.gov/pubmed/34267187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-021-00523-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados